Valeant Poised To Pursue Label Suits Over IBS Drug Copycats
A California federal judge said Thursday he'll likely allow Valeant to proceed with lawsuits alleging two pharmaceutical companies falsely advertised U.S. Food and Drug Administration approval of copycat versions of its...To view the full article, register now.
Already a subscriber? Click here to view full article